EXODIAB: Excellence of Diabetes Research in Sweden
191 – 200 of 4142
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Significance of understanding the genomics of host-pathogen interaction in limiting antibiotic resistance development : Lessons from COVID-19 pandemic
(
- Contribution to journal › Scientific review
-
Mark
Anxiety, depression and quality of life in relation to SARS-CoV-2 antibodies in individuals living with diabetes during the second wave of COVID-19
(
- Contribution to journal › Article
-
Mark
Response by Sayols-Baixeras et al to Letter Regarding Article, " Streptococcus Species Abundance in the Gut Is Linked to Subclinical Coronary Atherosclerosis in 8973 Participants From the SCAPIS Cohort"
(
- Contribution to journal › Letter
-
Mark
Genetic and phenotypic discordance in cardiometabolic diseases
2024) In Lund University, Faculty of Medicine Doctoral Dissertation Series(
- Thesis › Doctoral thesis (compilation)
-
Mark
Molecular basis for human aquaporin inhibition
(
- Contribution to journal › Article
-
Mark
Intracellular C3 protects β-cells from IL-1β-driven cytotoxicity via interaction with Fyn-related kinase
(
- Contribution to journal › Article
-
Mark
Human Genetic Variation at rs10071329 Correlates with Adiposity-related Traits, Modulates PPARGC1B Expression, and Alters Brown Adipocyte Function
2024) In Diabetes(
- Contribution to journal › Article
-
Mark
CVOT Summit Report 2023 : new cardiovascular, kidney, and metabolic outcomes
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Randomized open-label trial of semaglutide and dapagliflozin in patients with type 2 diabetes of different pathophysiology
(
- Contribution to journal › Article
-
Mark
Glycolytic enzyme Enolase-1 regulates insulin gene expression in pancreatic β-cell
(
- Contribution to journal › Article